Artemis Investment Management LLP Acquires 32,213 Shares of UnitedHealth Group Inc (UNH)

Artemis Investment Management LLP increased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 433,220 shares of the healthcare conglomerate’s stock after purchasing an additional 32,213 shares during the period. UnitedHealth Group makes up approximately 1.7% of Artemis Investment Management LLP’s portfolio, making the stock its 13th largest position. Artemis Investment Management LLP’s holdings in UnitedHealth Group were worth $84,824,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the second quarter worth approximately $110,000. Kings Point Capital Management boosted its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after acquiring an additional 150 shares during the last quarter. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. Finally, BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the second quarter worth approximately $121,000. 86.01% of the stock is owned by institutional investors.

UnitedHealth Group Inc (NYSE UNH) opened at $228.64 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market cap of $221,060.00, a PE ratio of 25.98, a price-to-earnings-growth ratio of 1.53 and a beta of 0.66. UnitedHealth Group Inc has a one year low of $156.09 and a one year high of $231.77.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the firm earned $2.17 EPS. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. equities research analysts predict that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

A number of equities analysts have weighed in on the stock. Evercore ISI reissued an “outperform” rating and issued a $255.00 target price (up previously from $235.00) on shares of UnitedHealth Group in a research note on Friday. Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research note on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target on the stock. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a research note on Monday, December 25th. Finally, ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $229.54.

In related news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock worth $7,669,416 over the last quarter. Insiders own 0.89% of the company’s stock.

WARNING: “Artemis Investment Management LLP Acquires 32,213 Shares of UnitedHealth Group Inc (UNH)” was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.thelincolnianonline.com/2018/01/14/artemis-investment-management-llp-purchases-32213-shares-of-unitedhealth-group-inc-unh-updated-updated.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply